These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11173633)

  • 1. The Expression of Lysosomal Proteinases and Their Inhibitors in Breast Cancer: Possible Relationship to Prognosis of the Disease.
    Lah TT; Kos J; Blejec A; Frkovic-Georgio S; Golouh R; Vrhovec I; Turk V
    Pathol Oncol Res; 1997; 3(2):89-99. PubMed ID: 11173633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma.
    Lah TT; Kokalj-Kunovar M; Strukelj B; Pungercar J; Barlic-Maganja D; Drobnic-Kosorok M; Kastelic L; Babnik J; Golouh R; Turk V
    Int J Cancer; 1992 Jan; 50(1):36-44. PubMed ID: 1728611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatins and cathepsins in breast carcinoma.
    Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
    Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
    Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
    Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
    Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
    Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
    Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
    Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
    Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
    Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
    Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
    Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
    J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
    Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
    Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma.
    Lah TT; Clifford JL; Helmer KM; Day NA; Moin K; Honn KV; Crissman JD; Sloane BF
    Biochim Biophys Acta; 1989 Oct; 993(1):63-73. PubMed ID: 2804124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsins D, B, and L in transformed human breast epithelial cells.
    Lah TT; Calaf G; Kalman E; Shinde BG; Somers R; Estrada S; Salero E; Russo J; Daskal I
    Breast Cancer Res Treat; 1996; 39(2):221-33. PubMed ID: 8872331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
    Werle B; Schanzenbächer U; Lah TT; Ebert E; Jülke B; Ebert W; Fiehn W; Kayser K; Spiess E; Abrahamson M; Kos J
    Oncol Rep; 2006 Oct; 16(4):647-55. PubMed ID: 16969475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.
    Strojnik T; Kos J; Zidanik B; Golouh R; Lah T
    Clin Cancer Res; 1999 Mar; 5(3):559-67. PubMed ID: 10100707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue.
    Ebert E; Werle B; Jülke B; Kopitar-Jerala N; Kos J; Lah T; Abrahamson M; Spiess E; Ebert W
    Adv Exp Med Biol; 1997; 421():259-65. PubMed ID: 9330706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsins D, B, and L in malignant human lung tissue.
    Ledakis P; Tester WT; Rosenberg N; Romero-Fischmann D; Daskal I; Lah TT
    Clin Cancer Res; 1996 Mar; 2(3):561-8. PubMed ID: 9816204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine proteinases in cancer progression and their clinical relevance for prognosis.
    Lah TT; Kos J
    Biol Chem; 1998 Feb; 379(2):125-30. PubMed ID: 9524063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.